Background : Diagnosing myocarditis is challenged by nonspecific clinical signs and
symptoms and low accuracy of endomyocardial biopsy. Cardiac magnetic resonance imaging (…

Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with
a median survival from diagnosis, if untreated, ranging from <6 months for light chain …

Aims In patients with transthyretin amyloid cardiomyopathy (ATTR-CM), the effect of tafamidis
on myocardial function using serial speckle tracking echocardiography has not been …

The primary aims of this study were to determine the correlation between absolute quantitative
99m Tc-pyrophosphate metrics and traditional measures of cardiac amyloid burden and …

Objectives The purpose of this study was to determine phenotypes characterizing cardiac
involvement in AL amyloidosis by using direct (fluorine-18-labeled florbetapir {[ 18 F]florbetapir…

Transthyretin cardiac amyloidosis (ATTR-CA) is an overlooked cause of heart failure, with
substantial morbidity and mortality. The emergence of several novel therapies has fueled the …

The systemic amyloidoses are a group of diseases characterized by the deposition of amyloid,
a material formed from misfolding of proteins, in one or more organs. The 2 commonest …

Aims African‐American carriers of the transthyretin (TTR) valine‐to‐isoleucine substitution (V122I)
are at increased risk of heart failure, yet many have relatively subtle abnormalities of …

Cardiac magnetic resonance offers multiple facets in the diagnosis, risk stratification, and
management of patients with myocardial diseases. Particularly, its feature to precisely monitor …

Background Cardiac amyloid quantification could advance early diagnosis of amyloid
cardiomyopathy (CMP) and treatment monitoring. However, current imaging tools are based on …